Mar. 23 -- TUESDAY, Nov. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved the Bristol-Myers Squibb antipsychotic drug Abilify (aripiprazole) for adolescents aged 13 to 17 ...
Otsuka Pharmaceutical Canada Inc. (OCPI) and Lundbeck Canada Inc. (Lundbeck) have secured coverage of ABILIFY ASIMTUFII® for over 90 per cent of Canadians covered by public drug plans and almost 60 ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Abilify Asimtufii? Abilify Asimtufii contains the ...
Kelly Blankenship, Craig A Erickson and Christopher J McDougle are supported in part by the Division of Disability and Rehabilitative Services, Indiana Family and Social Services Administration. Craig ...
Bristol-Myers Squibb Co. will pay $19.5 million to settle allegations that the London-based drugmaker improperly marketed and promoted its anti-psychotic drug Abilify, reports Reuters. The drugmaker ...
The co and Otsuka Pharmaceutical announces the FDA has accepted for filing and granted a Priority Review for the supplemental New Drug Application of Abilify for the treatment of adults with major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results